| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |